Increasing cases of CKD diseases are expected to contribute to the growth of the Bioimpedance devices market throughout the forecast period.
| Attribute | Details |
| Bioimpedance Devices Market Estimated Size 2022 | US$ 492.1 Mn |
| Bioimpedance Devices Market Value-based CAGR (2022-2028) | ~6.4% |
| Bioimpedance Devices Market Size in Projected 2028 | US$ 715.1 Mn |
Chronic kidney disease (CKD) is a medical condition characterised by a progressive decline in kidney function over time.
Millions of Americans are at high risk of developing CKD, and 30 million have chronic kidney disease, according to the National Kidney Foundation, Inc.
The Glomerular Filtration Rate (GFR) is the best overall index for studying kidney function.
Bioelectrical impedance, also known as bioimpedance, is used to more accurately estimate glomerular filtration rate and muscle mass in non-diabetic patients with chronic kidney disease.
Bioelectrical impedance analysis (BIA) can also be used to calculate appendicular lean mass (ALM).
Request Sample Copy of Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-5563
Demographic variables can be used to compare how well these equations estimate renal inulin clearance (GFR INU), as well as to modify diets for the treatment of renal disease (MDRD). Because of the widespread use of online marketing channels, sales of portable and hand-held Bioimpedance devices have increased significantly in recent years. According to one study, approximately 70% of Americans used online shopping portals to purchase various goods in 2015. Vendors in the bioimpedance device market are focusing on promotional tactics and online marketing to improve access to their devices and increase sales.
By utilizing the devices they provide online, vendors can reduce operational and distribution costs. Vendors can also use the online marketing channel to provide information about the devices in their portfolio and gain access to both local and international markets. Furthermore, these online marketing websites provide a wide range of high-quality Bioimpedance systems at low prices.
The majority of bioimpedance device manufacturers are focused on developing portable, low-cost products. Portable bioimpedance equipment is becoming increasingly popular due to its numerous advantages. Bioimpedance Devices, for example, are noninvasive, practical, safe, and simple to use.
Because these devices are small and portable, they are frequently used in home healthcare settings to monitor the health of everyone in the family. The sum of these factors is expected to drive demand for portable bioimpedance devices over the forecast period. People are also favouring portable/hand-held bioimpedance devices for travel. Because of its portability, the hand-held Bioimpedance device ImpediMed SFB7, for example, is in high demand. Over the forecast period, technological advancements to improve the quality of Bioimpedance devices and increase patient compliance are also expected to propel the market’s growth. Multiple-frequency bioimpedance devices are highly preferred because they can measure impedances at different frequencies. This provides a more precise and effective estimate of water within and outside of cells, as well as total body water.
Request a Complete TOC of this Report with figures @
https://www.futuremarketinsights.com/toc/rep-gb-5563
Single-frequency bioimpedance devices can determine total body water and fat-free mass, but they are unable to determine intracellular and extracellular body water.
Over the course of the forecast period, multiple-frequency Bioimpedance devices are anticipated to gain popularity and raise consumer awareness.
The market for bioimpedance devices has been divided into segments by product type, modality, and end user by FMI.
Single-frequency and multiple-frequency bioimpedance devices make up the two product categories in the bioimpedance devices market.
The market for bioimpedance devices is divided into two categories based on modality: wired and wireless bioimpedance devices.
The report tracks some of the key companies operating in the Bioimpedance Devices market, including General Electric Company, Omron Corporation, Fresenius Medical Care, ImpediMed Limited, SELVAS AI Inc., Tanita Corporation, RJL Systems, Inc., Maltron International Ltd., Bodystat Limited and SMT Medical GmbH.
Feel free to ask your queries @
https://www.futuremarketinsights.com/ask-question/rep-gb-5563
Bioimpedance Devices Market by Category Product Type:
- Single-frequency Bioimpedance Devices
- Multiple-frequency Bioimpedance Devices
Modality:
- Wired Bioimpedance Devices
- Wireless Bioimpedance Devices
End Users
- Hospitals
- Specialty Clinics
- Rehabilitation Centers
- Others
Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Japan
- Asia Pacific excluding Japan
- Middle East & Africa (MEA)
Read Related Reports:
https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028
About FMI
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/bioimpedance-device-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs